BSE Healthcare Corporate Filings & Announcements

Latest corporate announcements and filings from BSE Healthcare on BSE

Search Inside the pdf :

Sanofi India Ltd.

23 Apr 2025, 06:14PM

6440.50

1.16%

Company Update

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication is enclosed.

pdf

Senores Pharmaceuticals Ltd.

23 Apr 2025, 06:07PM

531.55

0.08%

Corp. Note

Senores Pharmaceuticals Ltd - 544319 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanySenores Pharmaceuticals Ltd 2CIN NO.L24290GJ2017PLC100263 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 84.31 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Vinay Kumar Mishra Designation: Company Secretary and Compliance Officer EmailId: cs@senorespharma.com Name of the Chief Financial Officer: Deval Rajnikant Shah Designation: Chief Financial Officer and Whole Time Director EmailId: dshah@senorespharma.com Date: 23/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Vimta Labs Ltd.

23 Apr 2025, 06:02PM

1048.20

6.83%

Company Update

Vimta Labs Ltd-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Analyst / Investor Conference call post announcement of Q4 Results for the FY 2024-25 to be held on Monday, 28th April 2025.

pdf

Sanofi Consumer Healthcare India Ltd.

23 Apr 2025, 05:57PM

4939.60

-0.13%

Corp. Note

Sanofi Consumer Healthcare India Ltd - 544250 - Reg. 34 (1) Annual Report.

BSE India

Corrigendum to the Annual Report for Financial Year 2024 due to inadvertent typographical errors in the disclosed figures on page no.53 under the section Foreign Exchange Earnings and Outgo. The figures should be read as: Total Foreign Exchange used: ?167 million and Total Foreign Exchange earned: ?685 million

pdf

RPG Life Sciences Ltd.

23 Apr 2025, 05:47PM

2315.70

2.57%

Investor Presentation

RPG Life Sciences Ltd - 532983 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Results Earnings Call for audited Financial Results of the Company for the quarter and half year ended Mar 31, 2025 will be held on Tuesday, April 29, 2025 at 3.30 p.m. IST. Please find below the dial-in-details for the said call. Dial-in Details: Indian (Universal) and Mumbai +91 22 6280 1116 +91 22 7115 8017 Location Toll Free Number US 18667462133 UK 08081011573 Singapore 8001012045 Hong Kong 800964448 Diamond Pass Link Link to register- https://tinyurl.com/f62v7vrw The investor presentation shall be shared with the Exchanges separately. You are requested to kindly take the same on record and disseminate appropriately.

pdf

Vimta Labs Ltd.

23 Apr 2025, 05:32PM

1048.20

6.83%

Corp. Action

Vimta Labs Ltd-$ - 524394 - Corporate Action-Board to consider Dividend

BSE India

The Board to consider and recommend the payment of Dividend, if any.

pdf

Vimta Labs Ltd.

23 Apr 2025, 05:22PM

1048.20

6.83%

Corp. Action

Vimta Labs Ltd-$ - 524394 - Corporate Action-Board to consider Bonus Issue

BSE India

Meeting of the Board of Directors is scheduled on Monday, 28th April,2025 and the board will consider the following agenda along with other agenda:- 1. Audited Financial Results 2. Recommend the payment of Dividend, if any. 3.To consider a proposal for issue of Bonus Shares

pdf

Vimta Labs Ltd.

23 Apr 2025, 05:09PM

1048.20

6.83%

Board Meeting

Vimta Labs Ltd-$ - 524394 - Board Meeting Intimation for This Is To Inform You That …

BSE India

Vimta Labs Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 ,inter alia, to consider and approve 1. The audited financial results for the fourth quarter and year ended 31st March 2025. 2. To recommend the payment of Dividend, if any, on equity shares of the Company for the financial year ended 31st March 2025. 3. To consider a proposal for issue of Bonus Shares, in accordance with the applicable provisions of the Companies Act, 2013 (including the rules and regulations framed thereunder) & the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018.

pdf